Skip to content

Gelweave™ 736012Recalls & reported problems

Vascutek Ltd · Gelweave Gelatin Impregnated Woven Vascular Prosthesis STRAIGHT · Class 2 · Implant

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05037881105345), received between Mar 25, 2025 and Mar 25, 2025 — classified as 1 malfunction.

The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fluid/Blood Leak1
  • Off-Label Use1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 25, 2025Fluid/Blood Leak; Off-Label Use; Fluid/Blood Leak; Off-Label Use

    A 7-YEAR-OLD CHILD WAS TREATED FOR IMPLANTATION OF A BERLIN HEART DUE TO RHYTHMIC DILATED HEART DISEASE ON THE (B)(6) 2025. IMPLANTATION OF THE DEVICE TOOK PLACE WITH THE NEED TO INSTALL A 12 MM DIAMETER DACRON (GELWEAVE STRAIGHT DEVICE) PROSTHESIS. A HEMOSTATIC RECOVERY WAS PERFORMED ON (B)(6) 2025. DURING THE PROCEDURE, ABNORMAL BLOOD OOZING WAS OBSERVED FROM THE PROSTHESIS TISSUE. THE SURGEON REINFORCED THIS TISSUE BY APPLYING A SPRAY OF "COSEAL" BIOLOGICAL GLUE TO ENSURE THE WATERTIGHTNESS OF THE SYSTEM. THE OOZING OBSERVED WAS GENERALIZED OVER THE ENTIRE PROSTHESIS AND WAS NOT LIMITED TO THE SUTURE AREAS. SURGICAL REVISION/ INTERVENTION WAS REQUIRED. THE HEART TRANSPLANT WAS CARRIED OUT LATER. THIS REPORT IS BEING SUBMITTED AS FOLLOW UP #1 FOR MANUFACTURING REPORT NUMBER 9612515-2025-00032 TO PROVIDE EVENT CLOSURE INFORMATION FOR (B)(4).

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 21686515 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.